SCHEMBL6357944

SCHEMBL6357944

O=C(O)c1cccc(S(=O)(=O)n2ccc3ccccc32)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.68
HTT P42858 3/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
ALDH1A1 P00352 2/20 0.68
LMNA P02545 1/20 0.68
HPGD P15428 1/20 0.68
TSHR P16473 1/20 0.68
HDAC3 O15379 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
PKM P14618 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9593014 0.88 HTR6 (0.61) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL9591962 0.85 HTR6 (0.58) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL2509437 0.83 RAPGEF4 (0.67) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL429849 0.82 HTR6 (1.00) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL29558135 0.82 HTR6 (1.00) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL27642789 0.81 HTR6 (0.60) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL1973635 0.81 HTR6 (0.69) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL27830593 0.81 PPARG (0.57) HTR6ALDH1A1AKR1C3AKR1C1PPARG
Hydrochloric Acid SCHEMBL28794299 0.80 HTR6 (0.96) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL6350593 0.79 PPARG (0.69) AKR1C3AKR1C1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318725-B2 Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2012-11-27 US disclosed
US-20110281849-A1 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-11-17 US disclosed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 HTR6 4311/4885HTT 2677/4885MEN1 3274/4885
US-20110281849-A1 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands HTR6, HTR1A, HTR2C HTR6 1/4885HTT 157/4885MEN1 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.